BNET Industries
Masimo is in the Health Care Industry
Latest News and Analysis
Low Perfusion-Resistant Pulse Oximetry
Low perfusion is a major contributor to the high rate of false alarms in pulse oximetry. Reducing the number of false alarms and giving reliable oximetric readings to the practitioner, even in the presence of low blood flow, are two major goals that must be attained by any pulse oximeter...
Major Reduction in Alarm Frequency With a New Pulse Oximeter
In general, intensive care monitor alarms are a major burden on both nurses and patients. Between 44% and 63% of alarms are caused by pulse oximeters, with 94% of these being non-significant. The high percentage of false alarms can result in potential delays in response or ignoring the alarms completely....
Pulse Oximetry in the Management of Children in the PICU
Maintaining vigilance is of paramount importance in any critical care unit. Eliminating excessive false alarms is essential in preventing the 'crying wolf syndrome' of decreased vigilance. There are numerous occasions in the PICU when false alarms from oximeters will be issued due to strong body motion or crying during procedures,...
Additional Resources
No Blood Needed Thanks to Innovative Medical Technology
SYDNEY, Australia, Sept. 26 /PRNewswire/ -- A non-invasive blood monitoring device that removes the need to draw blood to monitor patients has won the 2008 Kerrin Rennie Award for Excellence in Medical Technology. The award was presented to Masimo Corporation on 24 September at the Medical Technology Association of...
BellwetherReport.com Analyst Report on COMS, MASI, SHLD and AMSC
BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...
Masimo Reports Second Quarter 2008 Financial Results
Record results mark 20th consecutive quarter of revenue growth Q2 2008 Highlights: * Product revenues increased 30% to a record $61.9 million * Direct (Non-OEM) Business revenues increased by 46% * Shipped 29,000 new pulse oximeters and Pulse CO-Oximeters IRVINE, Calif., Aug. 4 ...
Examine the World Pulse Oximeters Market
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Pulse Oximeters Market http://www.reportlinker.com/p090661/World-Pulse-Oximeters-Market.html This report analyzes the worldwide markets for Pulse Oximeters in Thousands of US$. The major types of Pulse Oximeters analyzed...
Mergent, Inc. Announces Changes to the HealthShares™ Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes
NEW YORK, May 6 /PRNewswire/ -- Mergent, Inc., administrator for the HealthsharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the following changes with effect from the opening of trade on Friday, May 9, 2008: Masimo Corporation will replace Millennium Pharmaceuticals...
Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference
IRVINE, Calif., March 14 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through Motion & Low Perfusion pulse oximetry, today announced that it is scheduled to present at the Citi Investment Research 5th Annual Small & Mid-Cap Conference at The Four Seasons Hotel in Las Vegas,...
Current Review for Masimo Corporation.
M2 PRESSWIRE-27 February 2008-The SI Report: Current Review for Masimo CorporationC1994-2008 M2 COMMUNICATIONS LTD RDATE:27022008 Streetinvesting.com has now resumed our progressive review of Masimo Corporation (Nasdaq: MASI) after it traded up 7% Wednesday, early in the morning with average...
Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
Record results mark 18th consecutive quarter of revenue growth 2007 Highlights: * Product revenues increased 29% to a record $199.7 million * Masimo SET pulse oximeter units increase 20% to 116,300 units IRVINE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Masimo Corporation ,...
Masimo to Report Fourth Quarter and Fiscal Year 2007 Financial Results on February 26, 2008
Conference call and webcast with Masimo to begin at 2:00 pm PT (5:00 pm ET) IRVINE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, today announced it will release fourth quarter and fiscal year...
National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM)
To: BUSINESS EDITORS Contact: Dana Banks of Masimo Corporation, +1-949-297-7348 IRVINE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Masimo (Nasdaq:MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motionand Low Perfusion pulse oximetry, announced today that the NationalFire Protection Association NFPA has included Carbon Monoxide COscreening by Pulse CO-Oximetry as part of...
Pulse CO-oximetry monitor.(PRODUCT SHOWCASE: Monitoring Systems)
[ILLUSTRATION OMITTED] In addition to the ability to provide accurate pulse oximetry (Sp[O.sub.2]) readings in situations of motion and low perfusion, the Masimo Rainbow SET Pulse CO-Oximetry platform has recently been expanded to continuously and noninvasively monitor the level of carboxyhemoglobin SpCO...
Orion HealthCorp Announces Management Changes
ATLANTA -- Orion HealthCorp, Inc. (AMEX: ONH) today announced that Ronald D. Wentling has joined the Company as Director of Business Development and William J. Suffich III will be joining the Company on October 1 as Regional Vice President. The Company also announced that Stephen H. Murdock,...
New Welch Allyn Spot-Check and Patient Monitoring Devices Feature Masimo SET Pulse Oximetry Option
Spot Vital Signs[R] and Propaq[R] LT Devices Extend Read-Through Motion SpO2 Monitoring Capabilities to More Patients in More Settings SKANEATELES FALLS, N.Y. -- Welch Allyn, a leading global manufacturer of frontline medical products and solutions, and Masimo Corporation, the inventor of Pulse CO-Oximetry and Read-Through Motion and Low...
Bedside monitor
Masimo expands its Rainbow SET Pulse CO-Oximetry platform to provide in addition to accurate pulse oximetry (SpO2) readings in situations of motion and low perfusion--also continuous and noninvasive monitoring of levels of carboxyhemoglobin SpCO and methemoglobin SpMet in the blood, allowing for quick detection and treatment of...
Nihon Kohden America, Inc. and Masimo Announce Patient Monitoring Agreement
IRVINE, Calif. -- Nihon Kohden America, Inc., recognized as the fastest growing monitoring company in the United States, announced the signing of an agreement with Masimo Corporation. This new product offering will allow Nihon Kohden to integrate Masimo SET Signal Extraction Technology into their advanced line of...
New Research on the Global Market Perspective of Pulse Oximeters with Profiles of 84 Companies
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c41927) has announced the addition of Pulse Oximeters - Global Strategic Business Report to their offering. This report analyzes the worldwide markets for Pulse Oximeters in Thousands of US$. The major product segments analyzed are Stand-Alone Devices, and Multiparameter...
Masimo and Dolphin Announce Settlement of Patent Dispute
HAWTHORNE, Calif. -- Dolphin Medical, Inc. today announced that it will discontinue its Dolphin ONE product line. The discontinuation is part of an agreement between Dolphin and Masimo Corporation, in which Masimo has agreed to release Dolphin and its affiliates from certain patent infringement claims. ...
- Next »
- page 1 of 1
- « Previous
Sort byClose
Masimo Company Info
NAICS Code
Surgical and Medical Instrument Manufacturing: 339112
